Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00202488 · ClinicalTrials.gov registry record · Phase 2
The Effect of H. Pylori Infection on Iron Metabolism
A Phase 2 study of Iron Deficiency Anemia and Helicobacter Pylori Infection, sponsored by Seattle Institute for Biomedical and Clinical Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT00202488: Completed Phase 2 study of Iron Deficiency Anemia and Helicobacter Pylori Infection, sponsored by Seattle Institute for Biomedical and Clinical Research.
NCT00202488 is a Phase 2 study of Iron Deficiency Anemia and Helicobacter Pylori Infection that has completed, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 39 participants, below the 192-participant average among 24 other Iron Deficiency Anemia trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00202488, a Phase 2 study of Iron Deficiency Anemia and Helicobacter Pylori Infection, has completed, sponsored by Seattle Institute for Biomedical and Clinical Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if Helicobacter pylori (H. pylori) gastritis results in abnormal iron metabolism in patients with iron deficiency anemia (IDA), and to determine if this is due to strain variations in the H. pylori organism.
Conditions Studied
Interventions
- DRUG H. pylori treatment
Study Locations (1)
Washington
- VA Puget Sound Health Care System - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2002-11 |
| Est. Completion | 2007-09 |
| Phase | Phase 2 |
What the finished NCT00202488 record still lists
NCT00202488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 192-participant average among 24 other Iron Deficiency Anemia trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Iron Deficiency Anemia appearing as the primary indexed condition, and to 1 intervention - of which H. pylori treatment is the first listed.
NCT00202488 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00202488 about?
NCT00202488 is a clinical study titled "The Effect of H. Pylori Infection on Iron Metabolism". The purpose of this study is to determine if Helicobacter pylori (H. pylori) gastritis results in abnormal iron metabolism in patients with iron deficiency anemia (IDA), and to determine if this is due to strain variations in the H. pylori organism.
What is the current status of trial NCT00202488?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 39 participants. The study started on 2002-11. Estimated completion is 2007-09.
What conditions does trial NCT00202488 study?
This clinical trial studies the following conditions: Iron Deficiency Anemia, Helicobacter Pylori Infection.
What interventions are being tested in trial NCT00202488?
The interventions under investigation include: H. pylori treatment (DRUG).
Who is sponsoring clinical trial NCT00202488?
This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00202488 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Iron Deficiency Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00202488's enrollment target sits among peer trials
39 18th of 24 higher than 7 of 24 other Iron Deficiency Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Iron Deficiency Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
RECRUITING · Phase 2
-
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
COMPLETED · Phase 2
-
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
RECRUITING · Phase 3
-
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
RECRUITING · Phase 3
-
Iron Deficiency Anemia (IDA) and the Brain
RECRUITING · Phase 4
-
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia